Bruker Stock – Fundamental Analysis
Fundamental Data & Ratios (Balance sheet update: 7/14/2026)
| Balance Sheet | Total Assets | 6,241,400,000.00 | ROE | 39.36 % |
| Balance Sheet | Total Equity | 2,456,500,000.00 | ROA | -0.14 % |
| Cashflow | Capital Expenditures | -90,800,000.00 | P/FCF | 194.92 |
| Cashflow | Free Cash Flow | 43,300,000.00 | – | – |
| Cashflow | Operating Cash Flow | 134,100,000.00 | P/CF | 62.94 |
| Income | Earnings per Share (diluted) | -0.15 | Div. Yield | 0.36 % |
| Income | Net Income | -8,600,000.00 | P/E | -926.67 |
| Income | Shares Outstanding | 152,143,041.00 | P/B | 3.44 |
| Income | Total Revenue | 3,436,500,000.00 | P/S | 2.46 |
Ratios calculated on: 10/14/2026
Company Description
Bruker Corporation (Bruker) is a global manufacturer of scientific instruments that address the rapidly evolving needs of a diverse array of customers in life science, pharmaceutical, biotechnology, clinical and molecular diagnostics research, as well as in materials and chemical analysis in various industries and government applications. The Company´s technology platforms include magnetic resonance technologies, mass spectrometry technologies, gas chromatography technologies, X-ray technologies, spark-optical emission spectroscopy, atomic force microscopy, stylus and optical metrology technology and infrared and Raman molecular spectroscopy technologies. Its manufacture and distribute a broad range of field analytical systems for chemical, biological, radiological, nuclear and explosives, or CBRNE, detection. In April 2012, it acquired SkyScan N.V. In September 2013, the Company announced that it has acquired Prairie Technologies, Inc.
Additional comparison and history views are available after login.
Finanzoo GmbH assumes no liability for the accuracy of the information provided! All information is provided without guarantee. Sources: www.bundesanzeiger.de, www.sec.gov, www.bruker.com
All metrics and scores are an automated evaluation and not investment advice or a recommendation to buy or sell. Finanzoo GmbH or its shareholders may themselves hold positions in the securities shown.
Learn more